| MolName | (2Z)-2-cyano-2-[(5Z)-5-[[4-(3,5-diphenylpyrazol-1-yl)phenyl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-(furan-2-ylmethyl)acetamide |
| MolecularFormula | C39H27N5O3S |
| Smiles | N#C/C(/C(NCc1ccco1)=O)=C(\N(C1=O)c2ccccc2)/S/C1=C\c(cc1)ccc1-n(c(-c1ccccc1)c1)nc1-c1ccccc1 |
| InChI | InChI=1S/C39H27N5O3S/c40-25-33(37(45)41-26-32-17-10-22-47-32)39-43(30-15-8-3-9-16-30)38(46)36(48-39)23-27-18-20-31(21-19-27)44-35(29-13-6-2-7-14-29)24-34(42-44)28-11-4-1-5-12-28/h1-24H,26H2,(H,41,45) |
| InChIK | FEDXDKHGYMPVTQ-UHFFFAOYSA-N |
| TotalMolweight | 645.741 |
| Molweight | 645.741 |
| MonoisotopicMass | 645.18346 |
| CLogP | 6.2818 |
| CLogS | -9.102 |
| H Acceptors | 8 |
| H Donors | 1 |
| TotalSurfaceArea | 494.06 |
| Relative PSA | 0.21068 |
| PolarSurfaceArea | 129.46 |
| Druglikeness | 2.1258 |
| Mutagenic | high |
| Tumorigenic | low |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | polar activated DB; twice activated DB |
| Shape Index | 0.45833 |
| Fragments | 1 |
| Non HAtoms | 48 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 8 |
| Rings Closures | 7 |
| Small Rings | 7 |
| Aromatic Rings | 6 |
| Aromatic Atoms | 34 |
| Sp3Atoms | 2 |
| Symmetricatoms | 8 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - (2Z)-2-cyano-2-[(5Z)-5-[[4-(3,5-diphenylpyrazol-1-yl)phenyl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-(furan-2-ylmethyl)acetamide | 2 - (2Z)-2-cyano-2-[(5Z)-5-[[4-(3,5-diphenylpyrazol-1-yl)phenyl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-(furan-2-ylmethyl)acetamide